Letters by company
Lowes Companies INC
4 letters discussing LOW. Everything written about it on this site is on its ticker page.
- Auxier Asset Management Auxier Report: Fall 2026 Auxier Focus Fund tightened its emphasis on downside protection as debt-financed AI infrastructure spending, leverage and rising rates raised the risk of forced liquidations. The fund favored durable, founder-led businesses with free-cash-flow yields and strong balance sheets, while retaining short-term Treasuries until discounted opportunities emerge. Third Quarter 2026 META $1.6T0KFZ AMZN $2.9T
- Renaissance Investment Management — Large Cap Growth Large Cap Growth Intra-Quarter Commentary—August 2026 Large Cap Growth added NetApp and Eli Lilly, citing enterprise AI-storage demand and the expanding use of GLP-1 therapies. It exited AppLovin amid competitive pressure in gaming advertising and sold Lowe’s as expected revenue growth and margin expansion failed to emerge, while reassessing Tapestry and TJX after weaker outlook signals. Month Ending 8/31/2026 APP $134BDT $13BHALO $11B
- Matrix Asset Advisors Capital Markets Commentary and Quarterly Report: 2nd Quarter 2026 Matrix Asset Advisors added Consumer Staples, Healthcare and selected pressured Technology names while trimming holdings that had become oversized or reached target prices. The firm initiated Abbott Laboratories and McDonald’s in its dividend strategy, reduced equity overweighting in balanced accounts, and continued to favor bonds maturing within five years. 2nd Quarter 2026 ABT $186BMCD $193B
- Auxier Asset Management Auxier Report: Winter 2025 Auxier Focus Fund favored undervalued, cash-generative businesses as healthcare, banks, AI infrastructure suppliers and foreign holdings rebounded. The manager defended positions in UnitedHealth, housing, energy and selected software companies, while warning that AI capital spending, leverage and speculative valuations could produce sharp reversals. Fourth Quarter 2025 FISV $33B
